Eltrombopag for the Treatment of Poor Graft Function Following Haematopoietic Cell Transplantation: Real-Life Data

BACKGROUND: Eltrombopag has an off-label indication for haematopoietic cell transplantation in patients experiencing delayed thrombocyte recovery and/or thrombocytopaenia. AIMS: To present our centre’s experience of using this agent not only for post- haematopoietic cell transplantation thrombocytop...

Descripción completa

Detalles Bibliográficos
Autores principales: Kırcalı, Ekin, Cengiz Seval, Güldane, Öztürk, Cemaleddin, Yılmaz, Hülya, Koyun, Derya, Civriz Bozdağ, Sinem, Toprak, Selami Koçak, Topçuoğlu, Pervin, Arslan, Önder, Özcan, Muhit, Demirer, Taner, İlhan, Osman, Gürman, Günhan, Beksaç, Meral, Kurt Yüksel, Meltem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874246/
https://www.ncbi.nlm.nih.gov/pubmed/36571427
http://dx.doi.org/10.4274/balkanmedj.galenos.2022.2022-2-48

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874246/
https://www.ncbi.nlm.nih.gov/pubmed/36571427
http://dx.doi.org/10.4274/balkanmedj.galenos.2022.2022-2-48

Ejemplares similares